Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Chemoprevention × Resveratrol × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Colorectal Neoplasms 2 Colonic Neoplasms 2 Unspecified Adult Solid Tumor, Protocol Specific 1 Rectal Neoplasms 1 Polycystic Ovary Syndrome 1 Neuroendocrine Tumors 1 Neoplasms 1 Multiple Myeloma 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Follicular 1 Lymphangioleiomyomatosis 1 Liver Neoplasms 1 Gastro-enteropancreatic neuroendocrine tumor 1 Chemoprevention 1 Carcinoma, Hepatocellular 1

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04266353 2023-05-09

Effect of Resveratrol on Serum IGF2 Among African American Women

Loma Linda University

Phase NA Withdrawn

Chemoprevention

Data powered by HemOnc (CC BY 4.0) Colophon ⚡